Ingredient
Kojyl Methylenedioxycinnamate
Kojyl Methylenedioxycinnamate is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is absorbed into the body and hormone disruptor.
- Kojic Acid Methylenedioxycinnamate
- KMC
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Kojyl Methylenedioxycinnamate and pregnancy
Caution Advised
- Absorbed into the body
- Hormone disruptor
Kojyl methylenedioxycinnamate is a synthetic skin brightening ingredient that combines kojic acid with a cinnamic acid derivative. It's used to address hyperpigmentation by inhibiting melanin production. While melasma is common during pregnancy, the safety of this particular compound hasn't been established for use in pregnant women. The primary concern stems from the methylenedioxycinnamate component, which belongs to a class of cinnamic acid derivatives. Some compounds in this family have demonstrated weak estrogenic activity in laboratory studies, raising theoretical concerns about endocrine disruption during pregnancy. Additionally, there are no studies evaluating systemic absorption or fetal exposure from topical application. While pure kojic acid is sometimes considered during pregnancy for melasma, this specific derivative lacks safety data. Most dermatologists adopt a conservative approach with unstudied derivatives during pregnancy. ACOG recommends that pregnant women avoid medications and cosmetic ingredients with unknown safety profiles when effective alternatives exist. For pregnancy-safe brightening, dermatologists typically recommend ingredients like azelaic acid, vitamin C, or niacinamide, which have better-established safety data. If you're currently using this ingredient and are pregnant or planning pregnancy, consult your obstetrician or dermatologist about safer alternatives.
Kojyl Methylenedioxycinnamate and breastfeeding
Caution Advised
- Passes into breast milk
For breastfeeding mothers, kojyl methylenedioxycinnamate presents uncertainty due to complete lack of data on its transfer to breast milk or effects on breastfed infants. While topical kojic acid derivatives generally have low systemic absorption, the potential estrogenic activity of the methylenedioxycinnamate component creates theoretical concerns about infant hormone exposure. The AAD notes that ingredients with potential endocrine-disrupting properties warrant caution during breastfeeding, even in topical form. Given the availability of well-studied brightening alternatives and the lack of urgent need to treat hyperpigmentation during this period, many dermatologists would recommend postponing use of this ingredient until after weaning. If addressing postpartum melasma or hyperpigmentation is a priority, discuss safer alternatives with your dermatologist. Ingredients like vitamin C, niacinamide, and azelaic acid have better safety profiles for breastfeeding mothers and can effectively address pigmentation concerns.
Kojyl Methylenedioxycinnamate and postpartum
Safe to Use
- Irritant
- Increases sun sensitivity
For postpartum women not breastfeeding, kojyl methylenedioxycinnamate can be used to address pregnancy-related hyperpigmentation such as melasma or linea nigra. The ingredient's brightening properties may help fade these common postpartum concerns. Without the consideration of infant exposure through breastfeeding, the primary concerns are typical cosmetic ones: skin sensitivity and sun protection. If using this ingredient, strict sun protection is essential as it can increase photosensitivity. Start with lower concentrations and monitor for irritation, as postpartum skin can be more sensitive due to hormonal fluctuations. If you experience irritation or don't see results, consider switching to alternative brightening ingredients with more established efficacy data.
Kojyl Methylenedioxycinnamate and trying to conceive
Caution Advised
- Hormone disruptor
Women trying to conceive should approach kojyl methylenedioxycinnamate with the same caution as during pregnancy, since conception timing can be uncertain and early pregnancy is a critical developmental period. The theoretical concern about endocrine-disrupting properties, while not definitively established in humans, suggests a conservative approach. Given that brightening treatments are not medically necessary and that conception may occur at any time, many reproductive endocrinologists and dermatologists recommend switching to pregnancy-safe alternatives when actively trying to conceive. This ensures you're not exposed to any potentially concerning ingredients during the critical early weeks of pregnancy, which often occur before you know you're pregnant.
Kojyl Methylenedioxycinnamate and PCOS
Caution Advised
- Interferes with hormones
Kojyl methylenedioxycinnamate can help address hyperpigmentation and post-inflammatory marks from acne, both common concerns for women with PCOS. Its tyrosinase-inhibiting properties work to brighten skin and even tone. However, the potential estrogenic activity of the methylenedioxycinnamate component requires consideration for women with PCOS. While the evidence for hormonal effects is limited to laboratory studies and human relevance is uncertain, women with PCOS often have existing hormonal imbalances. Some endocrinologists and dermatologists who specialize in PCOS prefer that patients avoid ingredients with any potential endocrine-disrupting activity when well-studied alternatives exist. That said, topical absorption is generally low, and many women with PCOS use this ingredient without issues. If you have PCOS and are concerned about hormonal effects, consider alternative brightening ingredients like azelaic acid, niacinamide, or vitamin C, which have no hormonal concerns and can effectively address both hyperpigmentation and acne. If you choose to use kojyl methylenedioxycinnamate, monitor your skin response and any changes in PCOS symptoms, though significant hormonal effects from topical use are unlikely.
Kojyl Methylenedioxycinnamate and general use
Safe to Use
- Increases sun sensitivity
- Irritant
Kojyl methylenedioxycinnamate is a brightening and antioxidant ingredient designed to be a more stable alternative to pure kojic acid. It works by inhibiting tyrosinase, the enzyme responsible for melanin production, helping to fade dark spots, hyperpigmentation, and create more even skin tone. The methylenedioxycinnamate modification provides additional antioxidant properties. For the general population not pregnant or breastfeeding, this ingredient can be effective for addressing pigmentation concerns with potentially less irritation than traditional kojic acid. The main considerations are increased photosensitivity and possible skin irritation. Users must commit to strict sun protection when using this ingredient, as exposure can worsen pigmentation and potentially cause adverse reactions. If you have sensitive skin, start with products containing lower concentrations and gradually increase frequency. Always use broad-spectrum SPF 30 or higher during the day. Discontinue if you experience significant irritation, redness, or worsening of pigmentation. While this ingredient can be effective, alternatives like azelaic acid or niacinamide may offer similar benefits with better-established safety profiles.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Kojyl Methylenedioxycinnamate, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store